Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.110
-0.020 (-1.77%)
At close: Sep 18, 2026, 4:00 PM EDT
1.120
+0.010 (0.90%)
After-hours: Sep 18, 2026, 4:10 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $68.73 million as of September 18, 2026. Its market cap has decreased by -23.31% in one year.
Market Cap
68.73M
Enterprise Value
-60.62M
1-Year Change
-23.31%
Ranking
Category
Stock Price
$1.11
ChartMarket Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $68.73M, a decrease of -90.68%. That is a compound annual growth rate of -31.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 68.73M | -8.32% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eloxx Pharmaceuticals | 71.16M |
| RenovoRx | 69.95M |
| OKYO Pharma | 69.80M |
| Champions Oncology | 68.90M |
| Alterity Therapeutics | 67.69M |
| Gossamer Bio | 66.97M |
| Alps Group | 66.56M |
| XBiotech | 65.55M |